Uptake of orphan drugs in the WHO essential medicines lists
Enrico Costa(Brigham and Women's Hospital), Hubert G. M. Leufkens(Utrecht University), Lorenzo Moja(World Health Organization), Veronika J. Wirtz(Boston University), Benedikt Huttner(World Health Organization), Hendrika van den Ham(Pharmo Institute), Nicola Magrini(Azienda Unità Sanitaria Locale Della Romagna)
Cited by 16
Related Papers
Timing Matters in Hip Fracture Surgery: Patients Operated within 48 Hours Have Better Outcomes. A Meta-Analysis and Meta-Regression of over 190,000 Patients
|PLoS ONE|2012|631
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276
WHO global research priorities for antimicrobial resistance in human health
|The Lancet Microbe|2024|183
Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
|The Lancet Oncology|2021|170